Sleep disorders in patients diagnosed with Parkinson's disease at a specialized medical center in Rosario (Santa Fe, Argentina), 2024
DOI:
https://doi.org/10.62486/ijn2025241Keywords:
sleep disorders, Parkinson's disease, insomnia, tremors, rigidityAbstract
Introduction: Sleep disorders are a common complication in patients with Parkinson's disease (PD), significantly affecting their quality of life.
Objective: To describe the frequency of sleep disorders in patients diagnosed with Parkinson's disease at a specialized medical center in Rosario in 2024.
Materials and Methods: Quantitative, observational study with a descriptive cross-sectional and retrospective design. Conducted at the Le Sommeil Sleep Disorders specialized medical center. The population consisted of all patients over 18 years of age diagnosed with PD. The instrument used for data collection was a survey specifically designed for this study, reviewed and validated by specialists. The variables were analyzed using absolute and relative percentage frequencies.
Results: Seventy-one patients were analyzed; of these, 54% were male. The average age was 73.9 ± 10.9 years. The most common age group was 70–79 years. The highest number of patients diagnosed was recorded in the period 2020–2024, representing 57.7% of the total. On average, the time between the onset of symptoms and diagnosis was one year. Sixty-four point eight percent of patients had the right side as their dominant side. Sixty point six percent of patients reported tremor as the most common symptom. Insomnia was the most frequently reported sleep disorder symptom in 32.4% of patients. Tremor was the most common symptom in 64.8% of patients, with a greater presence on the right side of the body.
Conclusion: The results showed a higher prevalence of the disease in older men, with symptoms such as tremor and sleep disorders such as insomnia. In addition, a greater impact was observed on the right side of the body, both in motor symptoms and sleep disorders.
References
1. Abrams P, Cardozo L, Khoury S, Wein A. Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal (AI) incontinence. Incontinence: 6th International Consultation on Incontinence. Tokyo: 2017. ISBN 978-0-9569607-3-3. Disponible en: https://www.ics.org/publications/ici_6/Incontinence_6th_Edition_2017_eBook_v2.pdf
2. Allen RP, Picchietti DL, Auerbach M, Cho YW, Connor JR, Earley CJ, et al. International Restless Legs Syndrome Study Group (IRLSSG). Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children. Sleep Med. 2018;41:27–44. doi:10.1016/j.sleep.2017.11.1126
3. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien (IL): American Academy of Sleep Medicine; 2014. Disponible en: https://aasm.org/clinical-resources/international-classification-sleep-disorders/
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Arlington (VA): American Psychiatric Publishing; 2013. Disponible en: https://www.appi.org/DSM
5. American Society of Health-System Pharmacists. Protriptyline. In: AHFS Patient Medication Information. 2019. Disponible en: https://medlineplus.gov/druginfo/meds/a604025.html
6. Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, et al. Pain in Parkinson’s disease: facts and uncertainties. Eur J Neurol. 2018;25(7):917–e69. doi:10.1111/ene.13624
7. Bellosta Diago E, López del Val LJ, Santos Lasaosa S, López García E, Viloria Alebesque A. Relación entre el trastorno de conducta del sueño REM y el trastorno de control de impulsos en pacientes con enfermedad de Parkinson. Neurología. 2017;32(8):494–9. doi:10.1016/j.nrl.2016.02.008
8. Bharucha AE, Pemberton JH, Locke GR. American Gastroenterological Association technical review on constipation. Gastroenterology. 2013;144(1):218–38. doi:10.1053/j.gastro.2012.10.028
9. Cattaneo C, Jost WH. Pain in Parkinson's disease: pathophysiology, classification and treatment. J Integr Neurosci. 2023;22(5):132. doi:10.31083/j.jin2205132
10. Chacín J. Párkinson y sueño: diferencias entre hombres y mujeres. Conoce El Párkinson. 2024. Disponible en: https://conoceelparkinson.org/sintomas/parkinson-sueno-mujeres-hombres/
11. Chávez-León E, Ontiveros-Uribe M, Carrillo-Ruiz J. La enfermedad de Parkinson: neurología para psiquiatras. Salud Mental. 2013;36(4):315–21. doi:10.17711/sm.0185-3325.2013.038
12. Clavero P, Rodríguez-Oroz MC. Trastornos del sueño en la enfermedad de Parkinson y otros trastornos del movimiento. An Sist Sanit Navar. 2007;30(1):143–53. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272007000200013
13. Conoce el Párkinson. La relación entre párkinson y sueño. Conoce El Párkinson. 2023. Disponible en: https://conoceelparkinson.org/sintomas/parkinson-sueno-calidad-vida/
14. Crego P, María C. Prevalencia de insomnio y condicionantes ambientales en mayores de 65 años en atención primaria. Gerokomos. 2017;28(3):121–6. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1134-928X2017000300121
15. De Rui M, Inelmen EM, Trevisan C, Pigozzo S, Manzato E, Sergi G. Parkinson's disease and the non-motor symptoms: hyposmia, weight loss, osteosarcopenia. Aging Clin Exp Res. 2020;32(7):1211–8. doi:10.1007/s40520-020-01470-x
16. Esteve V, Carneiro J, Salazar G, Pou M, Tapia I, Fulquet M, Duarte V, Saurina A, Moreno F, Ramírez de Arellano M. Efectos de la rotigotina sobre la sintomatología, calidad de vida e higiene de sueño en el síndrome de piernas inquietas en hemodiálisis. Nefrología. 2017;37(4):421–7. doi:10.1016/j.nefro.2017.03.023
17. Farfán Alé F, Folgueira A, Luján S, Furnari A, Ponce de León M, Valiensi SM. Trastornos del sueño y depresión en la enfermedad de Parkinson. Vertex Rev Arg Psiquiatr. 2021;32(153):13–20. Disponible en: https://revistavertex.com.ar/ojs/index.php/vertex/article/view/100
18. Fundación Mayo para la Educación y la Investigación Médicas. Enfermedad de Parkinson - síntomas y causas. Mayo Clinic. 2024. Disponible en: https://www.mayoclinic.org/es/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055
19. Goldstein DS. The catecholaldehyde hypothesis for the pathogenesis of catecholaminergic neurodegeneration: what we know and what we do not know. Int J Mol Sci. 2021;22(1):1–26. doi:10.3390/ijms22010222
20. González-Naranjo JE, Alfonso-Alfonso M, Grass-Fernandez D, Morales-Chacón LM, Pedroso-Ibáñez I, Ricardo-de la Fe Y. Analysis of sleep macrostructure in patients diagnosed with Parkinson's disease. Behav Sci. 2019;9(1):6. doi:10.3390/bs9010006
21. González-Usigli H. Enfermedad de Parkinson. Manual MSD versión para profesionales. 2020. Disponible en: https://www.msdmanuals.com/es/professional/trastornos-neurol%C3%B3gicos/trastornos-del-movimiento-y-cerebelosos/enfermedad-de-parkinson
22. Grimes D, Fitzpatrick M, Gordon J, Miyasaki J, Fon EA, Schlossmacher M, et al. Canadian guideline for Parkinson disease. CMAJ. 2019;191(36):E989–E1004. doi:10.1503/cmaj.181504
23. Högl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration. Nat Rev Neurol. 2018;14(1):40–55. doi:10.1038/nrneurol.2017.157
24. Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, et al. Position paper on olfactory dysfunction. Rhinology Suppl. 2017;54(26):1–30. doi:10.4193/Rhino16.248
25. Instituto Nacional de Enfermedades Neurológicas y Accidentes Cerebrovasculares (NINDS). Sleep: A dynamic activity. En: Brain Basics: Understanding Sleep. 2007. Disponible en: https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Understanding-Sleep
26. Jameson JL, Kasper DL, Fauci AS, Hauser SL, Longo DL, Loscalzo J, eds. Harrison’s Principles of Internal Medicine. 20th ed. New York: McGraw-Hill Education; 2018. Disponible en: https://accessmedicina.mhmedical.com/content.aspx?bookid=2461§ionid=212914039
27. Jellinger KA. Mood disorders in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2019;90(5):542–52. doi:10.1136/jnnp-2018-319222
28. Larøi F, Sommer EI, Blom JD, Fernyhough C, Ffytche D, Hugdahl K, et al. The characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions. Schizophr Bull. 2012;38(4):724–33. doi:10.1093/schbul/sbs061
29. Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990;39(1):151–70. doi:10.1016/0306-4522(90)90229-W
30. LeWitt PA, Chaudhuri KR. Unmet needs in Parkinson disease: motor and non-motor. Parkinsonism Relat Disord. 2020;80:7–12. doi:10.1016/j.parkreldis.2020.09.024
31. Long K, Wan C, Xiang Y, Liu J, Xu Q, Sun Q, et al. Study on the clinical features of Parkinson's disease with probable rapid eye movement sleep behavior disorder. Front Neurol. 2020;11:979. doi:10.3389/fneur.2020.00979
32. Luna-Herrera C, Martínez-Dávila IA, Soto-Rojas LO, Flores-Martínez YM, Fernández-Parrilla MA, Ayala-Dávila J, et al. Intranigral administration of β-sitosterol-β-D-glucoside elicits neurotoxic A1 astrocyte reactivity and chronic neuroinflammation in the rat substantia nigra. J Immunol Res. 2020;2020:5907591. doi:10.1155/2020/5907591
33. Maggi G, Trojano L, Barone P, Santangelo G. Sleep disorders and cognitive dysfunctions in Parkinson's disease: a meta-analytic study. Neuropsychol Rev. 2021;31(4):643–82. doi:10.1007/s11065-020-09473-2
34. Marie L. PD’s effect on sleep. In: The complete guide for people with Parkinson’s disease and their loved ones. 2020. p.79–81. doi:10.2307/j.ctv15wxntx.33
35. Marín D, Carmona H, Ibarra M, Gámez M. Enfermedad de Parkinson: fisiopatología, diagnóstico y tratamiento. Rev Univ Ind Santander Salud. 2018;50(1):79–92. doi:10.18273/revsal.v50n1-2018008
36. Martínez Ramírez D. Trastornos del sueño en Parkinson. UFHealth University of Florida Health. 2016. Disponible en: https://movementdisorders.ufhealth.org/2016/05/13/trastornos-del-sueno-en-parkinson/
37. Miranda CM, Kuljiš ARO. Trastornos del sueño en las enfermedades neurodegenerativas. Rev Chil Neuro-Psiquiatr. 2013;51(3):207–20. doi:10.1016/S0716-8640(13)70181-0
38. Mondragón-Rezola E, Arratibel-Echarren I, Ruiz-Martínez J, Martí-Massó JF. Sleep disorders in Parkinson's disease: insomnia and sleep fragmentation, daytime hypersomnia, alterations to the circadian rhythm and sleep apnea syndrome. Rev Neurol. 2010;50(Suppl 2):S21–6. doi:10.33588/rn.50S02.2009735
39. Morales-Martínez A, Martínez-Gómez PA, Martínez-Fong D, Villegas-Rojas MM, Pérez-Severiano F, Del Toro-Colín MA, et al. Oxidative stress and mitochondrial complex I dysfunction correlate with neurodegeneration in an α-synucleinopathy animal model. Int J Mol Sci. 2022;23(19):11394. doi:10.3390/ijms231911394
40. Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson's disease. Lancet. 2024;403(10423):293–304. doi:10.1016/S0140-6736(23)01478-2
41. Naranjo J, Alfonso M, Delgado A, Chacón L, Rodríguez A. Trastornos del sueño en pacientes con enfermedad de Parkinson. Rev Cub Neurol Neurocir. 2020;10(1). Disponible en: https://revneuro.sld.cu/index.php/neu/article/view/346
42. Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, et al. Past, present, and future of Parkinson's disease: a special essay on the 200th anniversary of the shaking palsy. Mov Disord. 2017;32(9):1264–310. doi:10.1002/mds.27115
43. Ogaki K, Fujita H, Nozawa N, Shiina T, Sakuramoto H, Suzuki K. Factors contributing to sleep disturbances and excessive daytime sleepiness in patients with Parkinson's disease. Front Neurol. 2023;14:1097251. doi:10.3389/fneur.2023.1097251
44. Ozawa M, Murakami H, Shiraishi T, Umehara T, Omoto S, Iguchi Y. Rapid eye movement sleep behavior disorder is associated with decreased quality of life and stigma in people with Parkinson's disease. Acta Neurol Belg. 2023;123(3):1073–9. doi:10.1007/s13760-022-02098-4
45. Park KW, Jo S, Lee SH, Hwang YS, Lee D, Ryu HS, Chung SJ. Therapeutic effect of levodopa/carbidopa/entacapone on sleep disturbance in patients with Parkinson's disease. J Mov Disord. 2020;13(3):205–12. doi:10.14802/jmd.20055
46. Parkinson’s Foundation. Postura encorvada. Parkinson’s Foundation [Internet]. 2024 [citado 2025 oct 11]. Disponible en: https://www.parkinson.org/espanol/entendiendo-parkinson/sintomas-motores/postura-encorvada
47. Pasquini J, Durcan R, Wiblin L, Gersel Stokholm M, Rochester L, Brooks DJ, et al. Clinical implications of early caudate dysfunction in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2019;90(10):1098–104. doi:10.1136/jnnp-2018-320157
48. Paul AM, Salas RE. Insomnia. Prim Care. 2024;51(2):299–310. doi:10.1016/j.pop.2024.02.002
49. Programa de Epidemiología de los Centros para el Control y la Prevención de Enfermedades (CDC). Perceived insufficient rest or sleep among adults—United States, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(42):1175–9.
50. Rooper AH, Samuels MA, Klein JP, Prasad S. Principios de la neurología. 11a ed. New York: McGraw-Hill; 2020.
51. Roychowdhury S, Forsyth D. Sleep disturbance in Parkinson disease. J Clin Gerontol Geriatr. 2012;3(2):53–61. doi:10.1016/j.jcgg.2012.04.002
52. Roychowdhury S, Forsyth D. Etiología y tratamiento de los trastornos del sueño en pacientes con enfermedad de Parkinson. J Clin Gerontol Geriatr. 2012;3(2):53–61. Disponible en: https://www.bago.com.ar/vademecum/bibliografia/etiologia-y-tratamiento-de-los-trastornos-del-sueno-en-pacientes-con-enfermedad-de-parkinson/
53. Rutten S, Vriend C, Smit JH, Berendse HW, Van Someren EJW, Hoogendoorn AW, et al. Bright light therapy for depression in Parkinson disease: a randomized controlled trial. Neurology. 2019;92(11):e1145–56. doi:10.1212/WNL.0000000000007090
54. Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H; Parkinson's Disease Subcommittee, Neurourology Promotion Committee, International Continence Society. A guideline for the management of bladder dysfunction in Parkinson’s disease and other gait disorders. Neurourol Urodyn. 2016;35(5):551–63. doi:10.1002/nau.22764
55. Scanga A, Benedetti A, Kimoff J, Lafontaine AL, Robinson A, Gingras M, et al. Exploring obstructive sleep apnea and sleep architecture in Parkinson’s disease motor subtypes. Parkinsonism Relat Disord. 2024;122:106064. doi:10.1016/j.parkreldis.2024.106064
56. Semple D, Smyth R. Trastornos del sueño-vigilia. En: Semple D, Smyth R, editores. Oxford Handbook de Psiquiatría. Oxford: Oxford University Press; 2022. p.455–514.
57. Sen A, Tai XY. Sleep duration and executive function in adults. Curr Neurol Neurosci Rep. 2023;23(11):801–13. doi:10.1007/s11910-023-01309-8
58. Stefani A, Högl B. Sleep in Parkinson’s disease. Neuropsychopharmacology. 2020;45(1):121–8. doi:10.1038/s41386-019-0448-y
59. Thangaleela S, Sivamaruthi BS, Kesika P, Mariappan S, Rashmi S, Choeisoongnern T, et al. Neurological insights into sleep disorders in Parkinson’s disease. Brain Sci. 2023;13(8):1202. doi:10.3390/brainsci13081202
60. Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson's disease. Lancet Neurol. 2021;20(5):385–97. doi:10.1016/S1474-4422(21)00030-2
61. Velluti RA, Pedemonte M. Fisiología de la vigilia y el sueño. Montevideo: HUMANA; 2005. p.149.
62. Wallace DM, Wohlgemuth WK, Trotti LM, Amara AW, Malaty IA, Factor SA, et al. Practical evaluation and management of insomnia in Parkinson's disease: a review. Mov Disord Clin Pract. 2020;7(3):250–66. doi:10.1002/mdc3.1289
63. Winkelmann J, Allen RP, Högl B, Inoue Y, Oertel W, Salminen AV, et al. Treatment of restless legs syndrome: evidence-based review and implications for clinical practice. Mov Disord. 2018;33(7):1077–91. doi:10.1002/mds.27260
64. Xiao CM, Zhuang YC. Effect of health Baduanjin Qigong for mild to moderate Parkinson's disease. Geriatr Gerontol Int. 2016;16(8):911–9. doi:10.1111/ggi.12571
65. Yanuck SF. Microglial phagocytosis of neurons: diminishing neuronal loss in traumatic, infectious, inflammatory, and autoimmune CNS disorders. Front Psychiatry. 2019;10:712. doi:10.3389/fpsyt.2019.00712
66. Yoon SH, You DH, Na HK, Kang S, Baik K, Park M, et al. Parkinson's disease with hyposmia and dysautonomia: does it represent a distinct subtype? J Neurol. 2024; doi:10.1007/s00415-024-12332-1
67. Yoritaka A, Fukae J, Hatano T, Oda E, Hattori N. The direct cost of Parkinson disease at Juntendo Medical University Hospital, Japan. Intern Med. 2016;55(2):113–9. doi:10.2169/internalmedicine.55.4484.
Published
Issue
Section
License
Copyright (c) 2025 Kimberly Boschi de Abreu Cavalli , Fernando Filippini , Pablo Cortadi (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
